Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

The German Psoriasis Registry PsoBest was conducted in 2008 in order to investigate the long-term outcomes and safety of systemic treatments for moderate-to-severe psoriasis. Safety analysis of antipsoriatic drugs with special focus on serious adverse events (SAE) for infections, malignancies and ma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arch Dermatol Res
Autors principals: Reich, K., Mrowietz, U., Radtke, M. A., Thaci, D., Rustenbach, S. J., Spehr, C., Augustin, M.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2015
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4643107/
https://ncbi.nlm.nih.gov/pubmed/26358263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00403-015-1593-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars